{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:43:19Z","timestamp":1787229799621,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Axillary lymph node dissection (ALND) in patients with breast cancer has the potential to induce side-effects, including upper-limb lymphedema. Axillary reverse mapping (ARM) is a technique that enables discrimination of the lymphatic drainage of the breast from that of the upper limb in the axillary lymph node (LN) basin. If lymphedema is caused by removing these lymphatics and nodes in the upper limb, the possibility of identifying these lymphatics would enable surgeons to preserve them. The aim of this study is to determine the clinical relevance of selective axillary LN and lymphatic preservation by means of ARM. To minimize the risk of overlooking tumor-positive ARM nodes and the associated risk of undertreatment, we will only include patients with a tumor-positive sentinel lymph node (SLN). Patients who are candidates for ALND because of a proven positive axillary LN at clinical examination can be included in a registration study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods\/design<\/jats:title>\n            <jats:p>The study will enroll 280 patients diagnosed with SLN biopsy-proven metastasis of invasive breast cancer with an indication for a completion ALND. Patients will be randomized to undergo standard ALND or an ALND in which the ARM nodes and their corresponding lymphatics will be left <jats:italic>in situ<\/jats:italic>. Primary outcome is the presence of axillary surgery-related lymphedema at 6, 12, and 24 months post-operatively, measured by the water-displacement method. Secondary outcome measures include pain, paresthesia, numbness, and loss of shoulder mobility, quality of life, and axillary recurrence risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>The benefit of ALND in patients with a positive SLN is a subject of debate. For many patients, an ALND will remain the treatment of choice. This multicenter randomized trial will provide evidence of whether or not axillary LN preservation by means of ARM decreases the side-effects of an ALND. Enrolment of patients will start in April 2013 in five breast-cancer centers in the Netherlands, and is expected to conclude by April 2016.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.trialregister.nl\/trialreg\/admin\/rctview.asp?TC=3698\" ext-link-type=\"uri\">TC3698<\/jats:ext-link>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1745-6215-14-111","type":"journal-article","created":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T10:21:26Z","timestamp":1369390886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"14","author":[{"given":"Elisabeth G","family":"Klompenhouwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D","family":"Gobardhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martinus A","family":"Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri C","family":"Voogd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest JT","family":"Luiten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,25]]},"reference":[{"issue":"1","key":"1306_CR1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.1999.17.1.143","volume":"17","author":"TF Hack","year":"1999","unstructured":"Hack TF, Cohen L, Katz J, Robson LS, Goss P: Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol. 1999, 17 (1): 143-149.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1306_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1053\/ejso.2002.1385","volume":"29","author":"MP Schijven","year":"2003","unstructured":"Schijven MP, Vingerhoets AJ, Rutten HJ, Nieuwenhuijzen GA, Roumen RM, van Bussel ME: Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol. 2003, 29 (4): 341-350. 10.1053\/ejso.2002.1385.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"1306_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.breast.2004.09.010","volume":"14","author":"R Ronka","year":"2005","unstructured":"Ronka R, von Smitten K, Tasmuth T, Leidenius M: One-year morbidity after sentinel node biopsy and breast surgery. Breast. 2005, 14 (1): 28-36. 10.1016\/j.breast.2004.09.010.","journal-title":"Breast"},{"issue":"7","key":"1306_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/jso.20905","volume":"97","author":"VS Klimberg","year":"2008","unstructured":"Klimberg VS: A new concept toward the prevention of lymphoedema: axillary reverse mapping. J Surg Oncol. 2008, 97 (7): 563-564. 10.1002\/jso.20905.","journal-title":"J Surg Oncol"},{"issue":"1","key":"1306_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1245\/s10434-007-9663-6","volume":"15","author":"R Ponzone","year":"2008","unstructured":"Ponzone R, Mininanni P, Cassina E, Sismondi P: Axillary reverse mapping in breast cancer: can we spare what we find?. Ann Surg Oncol. 2008, 15 (1): 390-391. 10.1245\/s10434-007-9663-6. author reply 2\u20133","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"1306_CR6","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1245\/s10434-007-9450-4","volume":"14","author":"C Nos","year":"2007","unstructured":"Nos C, Lesieur B, Clough KB, Lecuru F: Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Ann Surg Oncol. 2007, 14 (9): 2490-2496. 10.1245\/s10434-007-9450-4.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"1306_CR7","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1245\/s10434-007-9412-x","volume":"14","author":"M Thompson","year":"2007","unstructured":"Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC: Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol. 2007, 14 (6): 1890-1895. 10.1245\/s10434-007-9412-x.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"1306_CR8","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jamcollsurg.2007.12.022","volume":"206","author":"C Boneti","year":"2008","unstructured":"Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman RS: Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphoedema during sentinel lymph node biopsy. J Am Coll Surg. 2008, 206 (5): 1038-1042. 10.1016\/j.jamcollsurg.2007.12.022. discussion 42\u20134","journal-title":"J Am Coll Surg"},{"issue":"11","key":"1306_CR9","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1245\/s10434-008-0118-5","volume":"15","author":"F Casabona","year":"2008","unstructured":"Casabona F, Bogliolo S, Ferrero S, Boccardo F, Campisi C: Axillary reverse mapping in breast cancer: a new microsurgical lymphatic-venous procedure in the prevention of arm lymphoedema. Ann Surg Oncol. 2008, 15 (11): 3318-3319. 10.1245\/s10434-008-0118-5.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"1306_CR10","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1245\/s10434-009-0554-x","volume":"16","author":"F Casabona","year":"2009","unstructured":"Casabona F, Bogliolo S, Valenzano Menada M, Sala P, Villa G, Ferrero S: Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients. Ann Surg Oncol. 2009, 16 (9): 2459-2463. 10.1245\/s10434-009-0554-x.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"1306_CR11","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1245\/s10434-008-0030-z","volume":"15","author":"C Nos","year":"2008","unstructured":"Nos C, Kaufmann G, Clough KB, Collignon MA, Zerbib E, Cusumano P: Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol. 2008, 15 (9): 2550-2555. 10.1245\/s10434-008-0030-z.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"1306_CR12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jso.21473","volume":"101","author":"M Noguchi","year":"2010","unstructured":"Noguchi M, Yokoi M, Nakano Y: Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer. J Surg Oncol. 2010, 101 (3): 217-221.","journal-title":"J Surg Oncol"},{"issue":"6","key":"1306_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MNM.0b013e328315a6c6","volume":"30","author":"TB Britton","year":"2009","unstructured":"Britton TB, Solanki CK, Pinder SE, Mortimer PS, Peters AM, Purushotham AD: Lymphatic drainage pathways of the breast and the upper limb. Nucl Med Commun. 2009, 30 (6): 427-430. 10.1097\/MNM.0b013e328315a6c6.","journal-title":"Nucl Med Commun"},{"issue":"3","key":"1306_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10549-009-0578-8","volume":"119","author":"M Noguchi","year":"2010","unstructured":"Noguchi M: Axillary reverse mapping for breast cancer. Breast Cancer Res Treat. 2010, 119 (3): 529-10.1007\/s10549-009-0578-8.","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"1306_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.ejso.2012.04.012","volume":"38","author":"PD Gobardhan","year":"2012","unstructured":"Gobardhan PD, Wijsman JH, van Dalen T, Klompenhouwer EG, van der Schelling GP, Los J, Voogd AC, Luiten EJ: ARM: axillary reverse mapping - the need for selection of patients. Eur J Surg Oncol. 2012, 38 (8): 657-661. 10.1016\/j.ejso.2012.04.012.","journal-title":"Eur J Surg Oncol"},{"key":"1306_CR16","first-page":"421","volume":"64","author":"C Boneti","year":"2012","unstructured":"Boneti C, Badgwell B, Roberton Y, Korourian S, Adkins L, Klimberg V: Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy. Minerva ginecol. 2012, 64: 421-430.","journal-title":"Minerva ginecol"},{"key":"1306_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10549-006-9213-0","volume":"99","author":"RJ Damstra","year":"2006","unstructured":"Damstra RJ, Glazenbrug EJ, Hop WCJ: Validation of the inverse water volumetry method: a new gold standard for arm volume measurements. Breast cancer res treat. 2006, 99: 267-273. 10.1007\/s10549-006-9213-0.","journal-title":"Breast cancer res treat"},{"issue":"12","key":"1306_CR18","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.ejso.2011.09.001","volume":"37","author":"TR Lopez Penha","year":"2011","unstructured":"Lopez Penha TR, Slangen JJ, Heuts EM, Voogd AC, Von Meyenfeldt MF: Prevalence of lymphoedema more than five years after breast cancer treatment. Eur J Surg Oncol. 2011, 37 (12): 1059-1063. 10.1016\/j.ejso.2011.09.001.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"1306_CR19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0959-8049(01)00067-3","volume":"37","author":"JM Ververs","year":"2001","unstructured":"Ververs JM, Roumen RM, Vingerhoets AJ, Vreugdenhil G, Coebergh JW, Crommelin MA: Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer. 2001, 37 (8): 991-999. 10.1016\/S0959-8049(01)00067-3.","journal-title":"Eur J Cancer"},{"issue":"1","key":"1306_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/cncr.21568","volume":"106","author":"T Kim","year":"2006","unstructured":"Kim T, Giuliano AE, Lyman GH: Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006, 106 (1): 4-16. 10.1002\/cncr.21568.","journal-title":"Cancer"},{"issue":"5","key":"1306_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1200\/JCO.2008.21.7554","volume":"28","author":"ME Straver","year":"2010","unstructured":"Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J: Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol. 2010, 28 (5): 731-737. 10.1200\/JCO.2008.21.7554.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1306_CR22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa020128","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N: Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002, 347 (8): 567-575. 10.1056\/NEJMoa020128.","journal-title":"N Engl J Med"},{"issue":"6","key":"1306_CR23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW: Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011, 305 (6): 569-575. 10.1001\/jama.2011.90.","journal-title":"JAMA"},{"issue":"7","key":"1306_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ejso.2011.04.008","volume":"37","author":"A Avril","year":"2011","unstructured":"Avril A, Le Bouedec G, Lorimier G, Classe JM, Tunon-de-Lara C, Giard S: Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up. Eur J Surg Oncol. 2011, 37 (7): 563-570. 10.1016\/j.ejso.2011.04.008.","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"1306_CR25","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/BF01655182","volume":"9","author":"B Fisher","year":"1985","unstructured":"Fisher B, Wolmark N, Fisher ER, Deutsch M: Lumpectomy and axillary dissection for breast cancer: surgical, pathological, and radiation considerations. World J Surg. 1985, 9 (5): 692-698. 10.1007\/BF01655182.","journal-title":"World J Surg"},{"issue":"4","key":"1306_CR26","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.ijrobp.2007.07.2376","volume":"70","author":"M Deutsch","year":"2008","unstructured":"Deutsch M, Land S, Begovic M, Sharif S: The incidence of arm edema in women with breast cancer randomized on the National Surgical Adjuvant Breast and Bowel Project study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone. Int J Radiat Oncol Biol Phys. 2008, 70 (4): 1020-1024. 10.1016\/j.ijrobp.2007.07.2376.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1306_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.suronc.2006.11.003","volume":"15","author":"GH Sakorafas","year":"2006","unstructured":"Sakorafas GH, Peros G, Cataliotti L, Vlastos G: Lymphoedema following axillary lymph node dissection for breast cancer. Surg Oncol. 2006, 15 (3): 153-165. 10.1016\/j.suronc.2006.11.003.","journal-title":"Surg Oncol"},{"key":"1306_CR28","unstructured":"Dutch guideline for Breast Cancer Treatment:http:\/\/www.oncoline.nl\/mammacarcinoom,"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-14-111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:10:11Z","timestamp":1630541411000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-14-111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,25]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1306"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-14-111","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,25]]},"assertion":[{"value":"5 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"111"}}